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ORIGINAL ARTICLE
Maternal influence of prolyl endopeptidase on fat
mass of adult progeny
CH Warden1,2, JS Fisler3, G Espinal1, J Graham3,4, PJ Havel3,4 and B Perroud5
1Rowe Program in Genetics, University of California, Davis, CA, USA; 2Department of Pediatrics, Section of Neurobiology,
Physiology and Behavior, University of California, Davis, CA, USA; 3Department of Nutrition, University of California,
Davis, CA, USA; 4Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA,
USA and 5Genome Center, University of California, Davis, CA, USA
Background: Maternal genotype has lifetime effects on progeny, but few specific genes, and no proteases, are known to
underlie maternal effects. Prolyl endopeptidase (PREP) is a serine protease with putative substrates that regulate appetite or milk
production.
Objective: To test effects of PREP on obesity phenotypes in mice.
Design: Mice with a gene trap (GT) of PREP (PREPgt/gt) on the C57BL/6J (B6) background were generated. Minimal PREP protein
was detected by western blot. In Experiment 1, direct effects of PREP were measured in littermate mice derived from intercrosses
of heterozygotes (PREPWT/gt). In Experiment 2, maternal effects of PREP were measured in reciprocal crosses of heterozygous
(PREPWT/gt) and wild-type (WT) (PREPWT/WT) males and females.
Diets: Mice were fed either low-fat (LF, Experiments 1 and 2) or high-fat (HF, Experiment 1) defined diets.
Measurements: Adiposity index (AI) was calculated from body weight (BW) and weights of four fat depots measured in 120-
day-old mice. Fasting plasma glucose, insulin and leptin were measured. In vivo plasma a-MSH levels were measured by targeted
quantitative peptidomics.
Results: Experiment 1FIn intercross mice, there were significant diet effects, but few genotype effects. There were no genotype
effects on BW or AI in males or females on either diet. Experiment 2FIn contrast, reciprocal crosses of heterozygous males or
females with WT B6 revealed highly significant parent of origin effects on all traits except body length. Progeny (WT and
heterozygous genotypes and both sexes) born to female PREPWT/gt heterozygotes had fat pads that weighed as much as -
twofold more at 120 days old than progeny born to male heterozygotes.
Conclusion: Heterozygosity for PREP GT results in highly significant maternal effects, whereas homozygosity for the PREPgt/gt
mutation has a much more limited direct effect.
International Journal of Obesity advance online publication, 30 June 2009; doi:10.1038/ijo.2009.129
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Introduction
Many studies show that maternal diet influences obesity of
progeny in mouse models1,2 and human beings.3 However,
maternal influences on obesity are not restricted to diet:
they also include maternal genetic effects. Maternal genetic
effects occur when maternal genotype influences pheno-
types in progeny independent of progeny genotype.
Recently, several quantitative trait loci for maternal genetic
effects on the obesity of pups were identified.4 These studies
utilized F2 and F3 populations of Large  Small (LG SM)
mice in which all mice were genotyped, haplotyped,
phenotyped and the F3 progeny were cross fostered to
other F2 nurse mothers. The results showed that maternal
effects are located on several chromosomes. Maternal
genetic effects were also identified in studies of congenic
strains of mice.5
Prolyl endopeptidase (PREP, post-proline cleaving
enzyme, also prolyl oligopeptidase) was first isolated from
human uterus as an oxytocin-degrading enzyme.6
Putative substrates for PREP include substance P, TRH,
GnRH, arginine-vasopressin, angiotensins I–IV, bradykinin,
oxytocin, -endorphin, neurotensin, a-MSH, -casomorphin,Received 20 December 2008; revised 14 April 2009; accepted 18 May 2009
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LVV-hemorphin, urotensin and octadecaneuropeptide.7
Quantitative PCR and in situ hybridization reveal high levels
of PREP mRNA in cerebellum, hypothalamus, pituitary and
several other brain nuclei.8 Enzymatic studies identified
PREP activity in plasma. PREP mRNA and protein are also
located in testis, thymus and lung. PREP activity in uterus
and ovary varies strongly with estrous cycle.9
Serum PREP levels are correlated with depression, mania
and anorexia.10,11 PREP expression is also correlated to
Alzheimer’s disease and neurodegeneration, implicating
PREP activity in memory.12 No earlier studies suggest that
PREP influences obesity or report phenotypes of PREP-
deficient mice.
We examined the effects of minimal expression of PREP on
obesity phenotypes in mice. Analysis of intercross mice
derived from heterozygous parents reveals that PREP has few
direct genotype effects, primarily body weight (BW) and
adiposity index (AI) in females fed low-fat (LF) diet. In
contrast, heterozygosity for PREP gene trap (GT) (PREPWT/gt)
in female mice bred to wild-type (WT) (PREPWT/WT) male
mice leads to increased BW and fat mass in all progeny,
regardless of progeny genotype, when compared with
progeny produced from female PREPWT/WT bred to male
PREPWT/gt heterozygotes.
Materials and methods
Generation of PREP GT (PREPgt/gt) mice
PREP is located on mouse chromosome 10 at 44 MB on the
Ensembl version 49 mouse assembly. It has 15 exons, all of
which are predicted to include protein-coding sequence.
BayGenomics clone RRM213 (NHLBIFBay Area Functional
Genomics Consortium, http://baygenomics.ucsf.edu) was
identified as having an insertion in the second intron of
the PREP gene in a 129-strain ES cell. As protein coding
begins in the first exon, the resulting protein in the GT mice
would include the first 40 amino acids of this 710 residue
protein before the inserted b-galactosidase. Founder chimeric
mice were bred to B6. Progeny were genotyped for b-
galactosidase. Mice positive for b-galactosidase were main-
tained by backcrossing to B6. Presence of the 129-strain
congenic DNA surrounding the PREP gene was confirmed at
every generation by genotyping three microsatellite markers
polymorphic between 129 and B6. The markers bracket the
PREP gene: two proximal (D10Mit148 and D10Mit55) and
one distal (D10Mit36).
PREPgt/gt mice are born in expected Mendelian numbers in
litters of average size for the B6 background. The homo-
zygotes do not exhibit increased mortality or disease up to
120 days of age. We have not retained older mice.
Animal maintenance and diet
B6 mice were initially purchased from The Jackson Labora-
tory (The Jackson Laboratory, Bar Harbor, ME, USA) and
maintained for over 10 years in a breeding colony at
UC Davis.
All animals were kept in the same room with a 14-h light/
10 h dark cycle, 21±2 (s.d.) 1C temperature and 425%
humidity. Breeding and nursing mice were in shoe-box cages
with deionized water and breeding chow available ad libitum.
Pups were weaned at 3 weeks of age, separated by gender and
housed 3–5 mice in suspended wire cages with either a LF
diet (AIN-76A) or a high-fat (HF) diet and deionized water
available ad libitum. AIN-76A (Research Diets, Inc., New
Brunswick, NJ, USA) is a widely used purified control diet
that contains 20.8 kcal% protein (20.5 kcal% casein),
67.7 kcal% carbohydrate (51.3 kcal% sucrose) and 11.5 kcal%
fat as corn oil. The HF diet (D12492, Research Diets) is a
purified diet used in the study of obesity and diabetes. This
diet contains 20% kcal% protein (19.7 kcal% casein), 20 kcal
% carbohydrate (6.8 kcal% sucrose) and 60% of calories from
fat, predominantly lard with some soy oil.
Genetic crosses
In Experiment 1, heterozygous breeders from the cross of
PREPgt/gt and PREPWT/WT mice were inter-bred to produce
pups that were heterozygous PREPWT/gt (H), GT PREPgt/gt or
WT PREPWT/WT for PREP for testing of direct effects of PREP
on obesity phenotypes. In Experiment 2, a reciprocal cross of
H (m, f) WT (m, f) was used to test maternal effects of
PREPWT/gt on obesity phenotypes.
Food intake
For food intake measurements, a minimum of five mice per
genotype were singly housed in wire-bottom cages with
either LF or HF diet at 10 weeks of age and acclimated for 4
days before the start of the measurement period. Food intake
was measured at the end of 4 days and averaged to determine
daily intake.
Body composition and plasma phenotypes
At 120±3 (s.d.) days of age, mice were fasted for B15 h
before collection of blood through the retroorbital sinus
within 90 s of initiating ether anesthesia at B3 h into the
light phase of the diurnal cycle (1000 h). Blood samples were
collected in iced ethylenediaminetetraacetic acid and plasma
kept at 70 1C until analyzed. Anal to nasal length was
measured, and mice were killed by cervical dislocation. Four
white adipose depots, femoral, gonadal, retroperitoneal and
mesenteric, were dissected by the same individual to
minimize variation in technique and weighed as described
earlier.13 The weights of the four adipose depots were used to
calculate AI (total adipose depot weight/live BW100). AI is
strongly correlated with percent body fat14 and is used as a
surrogate for body fat percentage.
Plasma samples were analyzed in duplicate for glucose
by the glucose oxidase method (Thermo Electron, VIC,
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Australia, Cat. #TR15104), insulin by mouse ultrasensitive EIA
(ALPCO Diagnostics, Salem, NH, USA, Cat. # 80-INSMSU-E01)
and leptin by a mouse leptin ELISA kit (Millipore, St Charles,
MO, USA, Cat. # EZML-82 K). An index of insulin resistance
was calculated from fasting plasma glucose and insulin using
the homeostatic model assessment (HOMA) of insulin
resistance (HOMA-IR) that was developed for human beings,15
but is now used extensively in rodent models.16–18 The
HOMA-IR was calculated using the formula: fasting plasma
insulin (ng ml–1) fasting plasma glucose (mmol l–1)/
(22.50.0417).18
a-MSH plasma level
Plasma samples were suspended in an equal of volume
of 0.1% TFA in water. Samples were then centrifuged
at 17 000 g for 15 min at 4 1C. The supernatants were
run through Strata C18-E, 55 mM, 70A (Cat# 8B-S001-FBJ,
Phenomenex, Torrance, CA, USA) Sep-Paks according to the
manufacturers instructions. Sample were then frozen and
lyophilized. Sample extracts were solubilized with 50 ml 2%
acetonitrile, 0.1% formic acid and sonicated in an ultra sonic
bath for 10 min. 10 ml of samples were analyzed by mass
spectrometry using a Thermo TSQ Vantage with a Michrom
multidimensional liquid chromatography system and a CTC
Pal Autosampler. The column used is a Magic C18 (200 mm
150mm) set at a flow rate of 2ml min–1. Separation of
peptides was achieved by using a 90-min step gradient with a
mobile phase of varying concentration of acetonitrile (5 to
90%). Scan width was set at 0.002 and Q1 and Q3 peak widths
at 0.7. Peak areas for, respectively, 5 and 8 multiple reaction
monitoring (MRM) transitions of the prevalent þ3 charge
state, for both target peptides, a-MSH and g-MSH, were then
calculated using the software Xcalibur version 2.0.7.
Effect of dam BW on progeny
Dam BWs, litter sizes and average pup weights were
compared by parity and genotype in dams fed breeder chow.
Western blots
Protein was extracted from a variety of tissue samples.
Approximately 50 mg tissue was homogenized in 1 ml Rigor
buffer (50 mM KCl, 50 mM Tris, 5 mM EGTA, 2 mM NaN3, pH
7.5) supplemented with protease inhibitor cocktail (Roche
Cat# 1 697 498 001) on ice. The samples were centrifuged at
4 1C for 10 min at 14 000 g. The supernatant was retained and
used for western blot analysis. 10 mg of protein was run on
NuPAGE 4–12% Bis–Tris Gel and transferred to GE nitrocel-
lulose membrane. We performed Ponceau S staining on
unblocked membrane and blocked with 5% milk overnight
in a cold room. The membrane was blocked with primary
antibody (Abcam ab58988) for 30 min, washed three times
with TBST for 10 min, then blocked with secondary antibody
(Abcam ab6721) for 30 min and finally washed another four
times for 10 min with TBST.
Statistical analyses
Data are presented as means±s.e. A general linear model was
used to assess effects of pup genotype and diet or maternal
genotype and pup gender on body composition using JMP
(SAS Institute, Cary, NC, USA). Post hoc comparisons were by
Tukey’s HSD. A Bonferroni correction for multiple tests in
this study indicates that an ANOVA P-value of 0.001 is
statistically significant.
Statement of ethics
We certify that all applicable institutional and governmental
regulations concerning the ethical use of animals
were followed during this research. All animals were housed
and cared under conditions meeting National Institutes
of Health standards as stated in the Guide for Care and
Use of Laboratory Animals and American Association for
Accreditation of Laboratory Animal Care accreditation
standards. All animal use was conducted according to
Institutional Animal Care and Use Committee-approved
protocols.
Results
Confirmation of GT
Surveys of mRNA abundance, both BioGPS (https://
biogps.gnf.org/) and MPSS GEO (http://www.ncbi.nlm.nih.-
gov/geo/info/mouse-trans.html)19 reveal that PREP is
expressed in several tissues. Deficiency of PREP protein in
GT mice was confirmed by performing a western blot of
brain and kidney proteins from PREPWT/WT, PREPWT/gt and
PREPgt/gt mice fed either the LF or HF diet as shown in
Figure 1a and lung from mice fed only the LF diet in
Figure 1b. Additional western blots comparing lung, brain,
muscle, ovary, uterus and heart in PREPWT/WT and PREPgt/gt
mice fed only the LF diet are in Figure 1c. PREP was identified
by including recombinant PREP on the western blot. The
sample genotypes were verified by PCR. The antibody to
PREP was made to a synthetic peptide based on the amino-
terminal end of human PREP. PREP protein was present in
PREPWT/WT mice, reduced in PREPWT/gt and almost absent in
PREPgt/gt mice (Figure 1). There was no detectable effect of
diet on the amount of PREP protein in kidney and brain. The
amount of PREP in PREPgt/gt homozygotes varied from
undetectable in gastrocnemius muscle to easily visible in
brain. Detectable PREP protein in PREPgt/gt mice results from
alternative splicing to remove the -gal containing ‘GT’
exon. Our data show that efficiency of alternative splicing of
PREP varies between tissues, but in all tissues PREPgt/gt
exhibit reduced protein.
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Direct effects of PREPgt/gt on obesity phenotypes (Experiment 1)
Intercrosses of heterozygous (PREPgt/gtPREPWT/WT)
parents were used to determine direct genotype effects.
An intercross colony was maintained by breeding of
heterozygous parents. Obesity phenotypes of PREPWT/WT,
PREPWT/gt and PREPgt/gt littermates maintained on either
AIN or HF diet were compared. Few genotype effects of
PREP GT were observed in F2 animals. Figure 2 presents
BW and AI of female and male littermates of different
genotypes and diets from the intercross. Genders were
analyzed separately. Both genders show a strong diet effect
(Po0.0001) for both BW and AI (Figure 2). In female mice,
genotype effects for both BW and AI were not statistically
significant, although when analyzed individually, BW was
lower in PREPgt/gt than in PREPWT/WT mice, whereas AI was
lower in PREPWT/gt than in PREPWT/WT mice. There was a
significant genotype effect on BW for male mice
(P¼ 0.0003) with PREPWT/gt mice on the HF diet being
heavier than PREPgt/gt However, there were no genotype
effects on BW or AI in males fed the LF diet (Figure 2). We
also observed recessive genotype effects on kidney weight
in females fed the LF diet (P¼0.002) and BMI in males fed
the HF diet (Po0.0001), as PREPWT/WT and PREPWT/gt are
statistically indistinguishable, whereas PREPgt/gt are
significantly smaller (data not shown).
Data on fasting plasma insulin, leptin, glucose and
calculated HOMA-IR are presented in Table 1. In females,
leptin was significantly higher in mice fed the HF diet: no
other diet or genotype effects were observed. In males,
insulin, leptin, glucose and HOMA-IR are all higher in mice
HF diet fed groups: no genotype effects were observed.
In females (N¼30), leptin was strongly correlated with
AI (0.84) and to a lesser extent with insulin (0.58) and
HOMA-IR (0.57), and insulin was strongly correlated with
glucose (0.76) and HOMA-IR (0.95). In males (N¼36), leptin
was strongly correlated with AI (0.75) and to a lesser extent
with insulin (0.68) and HOMA-IR (0.69), and insulin was
strongly correlated with glucose (0.69) and HOMA-IR (0.96).
There were no significant effects on total cholesterol (data
not shown).
Using targeted quantitative proteomics, we measured the
active, N-acetylated and C-amidated a-MSH from the plasma
of PREPgt/gt mice and WT littermates. First, using MSMS on
a-MSH standard, we identified five MRM transitions that we
could then monitor in plasma samples. On account of the
variability encountered across the biological samples, we also
monitored g-MSH, another proopiomelanocortin-derived
peptide. g-MSH also results from the digestion of a
proopiomelanocortin-derived peptide by proprotein conver-
tase subtilisin/kexin type 2, but it lacks a proline and thus is
not a putative PREP substrate. We identified eight MRM
transitions using g-MSH standard and then quantitated g-
MSH in multiplex, that is in the same MS run as
a-MSH. We observed a close correlation between the two
hormones for each genotype: R2¼0.93 and R2¼0.90,
respectively, for the PREPgt/gt and WT genotypes (Figure 3).
When normalizing a-MSH with g-MSH levels, we detected a
statistically significant decrease (1.5-fold) of a-MSH in the
plasma of PREPgt/gt mice with a one-tailed Student t-test
P-value¼0.0016 (Figure 4).
Daily food intake was measured in male and female mice
of all three genotypes on both diets. There were no
significant genotype effects (data not shown).
Reciprocal cross reveals maternal effect on obesity (Experiment 2)
We examined the hypothesis that heterozygotes for the PREP
GT mutation will have a parent of origin effect on obesity. We
performed reciprocal crosses of PREPWT/gt PREPWT/WT using
mice that were at generation N8 of backcross. All animals
were phenotyped by the same protocol as for the intercross,
but using only the LF diet (Figure 5; Table 2). Pup genotype
had no effect on phenotypes in either gender (Figure 5) and
the pups of both genotypes were combined for analysis of
maternal effects. Progeny of heterozygous PREPWT/gt females
weighed significantly more and had significant greater fat
mass (AI) than progeny of WT PREPWT/WT mothers. Pups born
to heterozygous PREPWT/gt mothers also had higher body mass
index and organ weights, but not anal nasal length than pups
born to WT PREPWT/WT mothers (Table 2).
Comparison of intercross and reciprocal cross data reveals
maternal effects
Progeny from the intercross (Experiment 1) were compared
with progeny from the reciprocal cross (Experiment 2)
Figure 1 Western blot of PREP protein in tissues of PREPWT/WT, PREPWT/gt
and PREPgt/gt mice fed either LF or HF diets as well as recombinant PREP
protein: (a) brain and kidney; (b) lung; (c) brain, muscle, ovary, uterus, lung
and heart. See text for methods. The minimal PREP protein in PREPgt/gt mice
indicates that this mutation is a PREP hypomorph rather than a complete
deletion.
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Figure 2 Intercross mice (Experiment 1). BWs and AI of female and male PREP WT (PREPWT/WT, WT), heterozygote (PREPWT/gt, H) and GT (PREPgt/gt) fed LF AIN-76A
or HF diets and killed at 120 days of age. AI was calculated as (total adipose depot weight/live BW100). Data are presented as means±s.e. P-values were calculated
by ANOVA: Bonferroni correction for multiple tests sets significant P-value at p0.001. Post hoc comparisons were by Tukey’s HSD: means not sharing a letter differ
significantly (Pp0.05). Genders were analyzed separately by two-way ANOVA. Females: BW effect of diet, Po0.0001, effect of genotype, NS; AI effect of diet
Po0.0001, effect of genotype, NS. Males: BW effect of diet, Po0.0001, effect of genotype, P¼ 0.0003; AI effect of diet, Po0.0001, effect of genotype, NS.
Table 1 Fasting plasma insulin, leptin, glucose and calculated HOMA-IR of mice from the intercross (Experiment 1)
Diet Low –fat High fat 2-Way ANOVAa
Genotype PREPWT/WT
b
PREPWT/gt PREPgt/gt PREPWT/WT PREPWT/gt PREPgt/gt Diet Genotype Interaction
Females
Insulin ng ml1 0.14±0.03 0.21±0.03 0.15±0.03 0.22±0.04 0.46±0.11 0.19±0.02 NS NS NS
Leptin ng ml1 10.2±2.4c 8.4±3.2c 3.7±1.0c 22.9±14.1b,c 54.3±8.7a 40.4±9.6a,b o0.0001 NS NS
Glucose mmol l1 5.5±0.8 5.2±0.3 5.7±0.9 6.0±0.8 9.5±1.1 6.6±0.3 NS NS NS
HOMA-IR 9.5±2.9 10.9±1.1 10.3±3.8 14.7±3.5 50.6±18.1 13.2±1.4 NS NS NS
Males
Insulin ng ml1 0.13±0.04b 0.19±0.05b 0.18±0.03b 0.78±0.29a 0.31±0.07b 0.30±0.06 b o0.0001 NS NS
Leptin ng ml1 3.9±1.1c 6.7±3.0c 7.9±3.6c 34.2±4.1a 25.3±5.4a,b 13.0±4.8 bc o0.0001 NS NS
Glucose mmol l1 4.8±0.4c 5.3±0.4b,c 5.6±0.7b,c 10.9±1.7a 8.6±0.5a,b 7.0±2.0 abc o0.0001 NS NS
HOMA-IR 6.4±1.9b 10.9±3.3b 11.0±2.4b 101±44a 29.0±6.5b 24.7±9.5 b o0.0001 NS 0.0004
Data are means±s.e. aP-values were calculated by ANOVA: Bonferroni correction for multiple tests sets significant P-value atp0.001. Post hoc comparisons were by
Tukey’s HSD: means not sharing a letter differ significantly Pp0.05. bGroup sizes: females eating low-fat diet N¼6 each group; eating high-fat diet N¼ 4 each
group; males eating low-fat diet N¼8 each group; males eating high-fat diet PREPWT/WT, N¼ 3; PREPWT/gt, N¼ 5; PREPgt/gt, N¼ 4.
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(Figure 6). Pups of both PREPWT/WT and PREPWT/gt genotypes
are combined in this analysis, as there was no significant
effect of pup genotype on adiposity. The results support two
conclusions: first, obesity because of the PREP GT mutation
is either additive or dominant, as effects are observed when
breeding heterozygotes and second, data are consistent with
maternal effects on obesity. Males cannot be the cause of the
obesity phenotype, as they cannot both cause leanness in the
reciprocal PREPWT/gt male PREPWT/WT female cross and
obesity in the PREPWT/gt male PREPWT/gt female intercross.
Dam genotype and BW do not affect litter size or pup
birth weight (Table 3). Preliminary data from crosses of
PREPWT/WT, PREPWT/gt and PREPgt/gt females indicate that
dams become heavier with parity, but litter sizes and average
pup weights are unaffected.
Discussion
We produced GT mice that express minimal levels of PREP.
PREP GT has a strong maternal effect on BW and fat mass:
all progeny, regardless of PREP genotype, born to females
heterozygous for the PREP mutation (PREPWT/gt) are signi-
ficantly more obese than progeny born to WT (PREPWT/WT)
mothers mated to PREPWT/gt heterozygous fathers.
Our data do not distinguish whether the maternal effects
of PREP GT mutation are pre- or post-natal. The obesity
observed in progeny of PREP heterozygous females is not
secondary to maternal obesity, as PREP heterozygous females
are, if anything, leaner than WT females on the LF diet (see
Figure 2). In addition, increased BW in dams fed higher-fat
breeder chow did not result in pups of greater average BW at
birth (Table 3).
There is no evidence of altered glucose metabolism in the
PREP-deficient mice fed the LF diet (Table 1). And in female
mice, unlike males, even the HF diet did not result in
elevated glucose and insulin levels. This differential regula-
tion of insulin resistance by gender in B6 mice is likely
because of gonadal steroid production in females.20,21
Therefore, it is unlikely that gestational diabetes in the dams
could explain the increased obesity of pups born to PREP
heterozygous mothers.
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Figure 3 Quantitative-targeted peptidomics of a-MSH and g-MSH. Peak areas of the MRM transitions are combined and plotted on a log scale for each mouse.
Mice are sorted by genotype with the PREPgt/gt mice on the left side (id starting with GT) and the WT mice (PREPWT/WT id starting with WT) on the right. Linear
correlation between the two endogenous peptides underlines that g-MSH, which is not a putative PREP substrate, can be used as an endogenous control to
normalize a-MSH quantities across biological replicates.
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Figure 4 a-MSH plasma level determined by quantitative-targeted proteo-
mics. Average of MRM transitions combined peak areas shows a genotype
effect. There is 1.5-fold more a-MSH in the plasma of WT mice (N¼10) than
in homozygous GT mice (N¼9) (Student t-test P-value¼ 0.0016).
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When normalizing a-MSH with g-MSH levels, we detected
a genotype effect that was not observable when directly
comparing a-MSH between the two genotypes. The decrease
of a-MSH in plasma from PREPgt/gt is counter-intuitive, as
one could expect accumulation of a-MSH with reduced PREP
enzyme, as it digests a-MSH in vitro.22 Our hypothesis is that
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Figure 5 Reciprocal cross (Experiment 2). BW and AI of male and female pups with either WT (PREPWT/WT, WT) or heterozygous (PREPWT/gt, H) mothers in the
reciprocal cross and categorized by either the pup genotype or the maternal genotype. Pups were fed LF diet only. Data are means±s.e. See Figure 2 legend for
methods. Three-way ANOVA for both BW and AI: effect of gender, Po0.0001; effect of pup genotype, NS; effect of maternal genotype, Po0.0001; all interactions, NS.
Table 2 Body composition phenotypes of male and female pups of either wild-type (PREPWT/WT) or heterozygous (PREPWT/gt) mothers. Pups were fed LF diet only.
Data are means±s.e.
Maternal genotype Two-way ANOVAa
PREPWT/WT
b
PREPWT/gt PREPWT/WT PREPWT/gt Maternal genotype Gender of pups Interaction
Male pups Female pups
AN length (cm) 9.9±0.0a 10.0±0.0a 9.6±0.1b 9.6±0.0b NS o0.0001 NS
Body mass index 0.28±0.00b 0.31±0.00a 0.22±0.00d 0.25±0.00c o0.0001 o0.0001 NS
Liver weight (g) 0.97±0.02b 1.11±0.03a 0.88±0.02c 1.03±0.03a,b o0.0001 0.0006 NS
Kidney weight (g) 0.30±0.00b 0.32±0.01a 0.22±0.00d 0.24±0.00c o0.0001 o0.0001 NS
Spleen weight (g) 0.07±0.00b 0.09±0.00a 0.07±0.00b 0.08±0.00a o0.0001 NS NS
aP-values were calculated by ANOVA: Bonferroni correction for multiple tests sets significant P-value atp0.001. Post hoc comparisons were by Tukey’s HSD: means
not sharing a letter differ significantly Pp0.05. bGroup sizes: males, PREPWT/WT, N¼ 46; PREPWT/gt, N¼42; females, PREPWT/WT, N¼32; PREPWT/gt, N¼ 39.
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feedback inhibition of a-MSH production from the deacety-
lated form of a-MSH may result from decreased turnover of
a-MSH in a PREP-deficient mouse strain. Such a mechanism
would involve homeostatic sensing of a-MSH concentrations
as suggested in the pars intermedia of the marsh frog.23
We have also used targeted peptidomics to show that PREP
removes the penultimate valine from full-length acetylated
a-MSH with 13 amino acids (a-MSH113) to produce a
12-amino-acid form of a-MSH112.
24 We then show that
the substrate/product ratio of a-MSH113 to a-MSH112 is
increased in pituitaries of PREPgt/gt mice, proving that
a-MSH113 is an in vivo substrate for PREP. We have
furthermore shown that a-MSH112 does not stimulate
action potentials in melanocortin receptor-4 containing
neurons.25 In addition, the last three amino acids of a-
MSH113, KPV, have antiinflammatory effects.
26 These
results mean that the effect of PREP on a-MSH113 may
influence in vivo melanocortin signaling and inflammation.
The putative effects of PREP on vasopressin and oxytocin,6
which influence milk production, and the earlier presenta-
tion that inhibitors of PREP increase vasopressin levels in
some brain regions,8 support the hypothesis that alterations
of vasopressin and/or oxytocin by the PREPKO may lead to
the maternal obesity effects observed here.
Several specific genes exhibit parent of origin effects on
obesity. Gs-a influences obesity through an imprinting mechan-
ism in which deletion of the maternal allele causes obesity.27
Yellow coat color and obesity in the agouti viable yellow mouse
(Avy) is due to an intracisternal A particle inserted in the agouti
gene cause ectopic expression of agouti.28 Intracisternal A
particle methylation can also be influenced by maternal diet.29
There are no other known examples of maternal effects genes.
Thus, maternal effects because of a PREP GT mutation represent
a novel mechanism for maternal effects.
The present data not only illustrate a novel mechanism for
maternal genetic effects, but also suggest the possibility of
unintentional obesity from the inhibition of PREP in human
beings. PREP is a member of a serine protease family that can
be inhibited by natural and synthetic compounds. Natural
inhibitors were identified in hydrolysates of cheese, fish,30
wine,31 casein,32 unsaturated fatty acids33 and plant pheno-
lics.34 A survey of traditional Chinese medicinal plants
identified PREP inhibitors. Berberine, an extract from
Rhizoma coptidis, was identified as a PREP inhibitory
molecule.35 Thus, human beings could already self-admin-
ister PREP inhibitors using traditional medicinal extracts.
Several PREP inhibitors have been synthesized and tested
in animal models and human beings. Compound S 17092
improves memory in rodents and human beings.36 Inhibi-
tion of PREP by a single dose of compound S 17092 increased
hypothalamic a-MSH, although chronic treatment had no
effect.22 Inhibition of PREP by S 17092 also raised levels of
arg-vasopressin and TRH in some brain regions.37 Clinical
trials of S 17092 in human beings to test roles in cognitive
enhancement and mood stabilization have begun.38
Our results show a novel mechanism for maternal genetic
effects on obesity of adult progeny through a serine protease. It
is unlikely that PREP is the only protease that influences
maternal effects. In principle, any gene that influences in utero
or post-natal nutrition or care could cause maternal effects. As
there are many similar serine proteases and as PREP is
influenced by environmental factors such as food and tradi-
tional and pharmaceutical compounds, these results may
Table 3 Dam body weight, litter size and average pup weight by parity and genotype
Parity 1 Parity 2
Dam genotype Dam genotype
PREPWT/WT PREPWT/gt PREPgt/gt PREPWT/WT PREPWT/gt PREPgt/gt
Number of dams 1 4 6 3 4 10
Dam body wt (g)a 21.8 18.1±0.7 19.3±0.3 24.3±0.5 23.9±0.7 24.1±0.7
Litter size 8 8.3±0.5 6.7±0.9 8.7±0.7 6.0±0.7 8.6±0.4
Total number of pups 8 33 47 26 24 86
Average pup weight (g per litter) 1.28 1.28±0.04 1.22±0.02 1.29±0.05 1.34±0.03 1.28±0.01
Dams fed breeder chow. aTwo-way ANOVA: effect of parity, Po0.0001. All other P-values for table, NS.
Cross F2(H x H) 
Reciprocal
(H X WT)
Reciprocal
(H X WT)
F2
(H x H)
Maternal
genotype WTWT H HHH
P=NS P=NS
P=0.001 P<0.0001
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Figure 6 Maternal obesity effects of the PREP GT mutation on AI in male and
female pups. Values are mean±s.e. See Figure 2 legend for methods. There
are no significant differences between mice born to PREPWT/gt mothers. The F2
intercross has only PREPWT/gt heterozygous mothers. Pup genotypes were
PREPWT/gt or PREPWT/WT and are combined in this analysis, as there was no
genotype difference. Male and female heterozygous breeders in the reciprocal
cross were littermates of PREPWT/WT PREPWT/gt crosses.
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illustrate a prevalent protease action mode. This could have
broad significance for discovery of additional maternal genetic
effects and for the relevance of PREP to obesity.
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